- Frequently Asked Questions
All the information about pharmacogenetics, preventive medicine that improves your quality of life.
Pharmacogenetic tests are not diagnostic tests and do not predict diseases or conditions. They are used to predict how your body will respond to medication based on your genetic code. By identifying incompatibility risks, the test allows you to make more informed choices knowing that some medications may cause you undesirable side effects or be ineffective. It is also important to note that other factors may influence your reaction to drugs.
No, although some drugs may have dosing recommendations, we can also recommend that you simply avoid certain drugs, or use them with caution, or as indicated on the drug label.
We need a small saliva sample, about 1 ml of saliva, or 1/5th of a teaspoon.
It takes 1 to 2 weeks from the date your saliva sample is received at the BiogeniQ laboratory.
The recommendations included in our reports are drawn from peer-reviewed scientific publications. For the Pharma Profile, some recommendations may also come from the medication labels issued by Health Canada or other organizations such as the Food and Drug Administration (FDA). BiogeniQ ensures that the information in your report comes from credible scientific sources and experts in the field.
No, you do not need a prescription to make the appointment. However, if you have a prescription that mentions “Genetic counselling” or “Meeting with a genetic counsellor”, the consultation will be tax free.
Between 2 and 4 weeks, depending on the type of test requested. In an emergency with medical justification, an express request (7-12 days) can be submitted.
The vast majority of tests require a saliva sample. This type of sample can be taken at home or at a point of service. In some cases, a blood sample is needed and is taken at a point of service.
No, it’s not a diagnosis, but rather a prognosis. For example, we test for genes that predispose people for cancer. The test tells you the risk percentage of developing breast cancer.
If an insurance company asks you if you’ve had a genetic test done, you don’t have to answer that question. You can refer to Bill S-201.